- Home
- IMXI vs KROS Comparison
IMXI vs KROS Comparison
Compare IMXI & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMXI
- KROS
- Stock Information
- Founded
- IMXI 1994
- KROS 2015
- Country
- IMXI United States
- KROS United States
- Employees
- IMXI N/A
- KROS N/A
- Industry
- IMXI Retail: Computer Software & Peripheral Equipment
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- IMXI Technology
- KROS Health Care
- Exchange
- IMXI Nasdaq
- KROS Nasdaq
- Market Cap
- IMXI 278.2M
- KROS 565.0M
- IPO Year
- IMXI N/A
- KROS 2020
- Fundamental
- Price
- IMXI $14.50
- KROS $15.55
- Analyst Decision
- IMXI Buy
- KROS Buy
- Analyst Count
- IMXI 6
- KROS 14
- Target Price
- IMXI $19.60
- KROS $20.56
- AVG Volume (30 Days)
- IMXI 475.6K
- KROS 417.3K
- Earning Date
- IMXI 11-07-2025
- KROS 11-05-2025
- Dividend Yield
- IMXI N/A
- KROS N/A
- EPS Growth
- IMXI N/A
- KROS N/A
- EPS
- IMXI 1.65
- KROS 0.47
- Revenue
- IMXI $642,149,000.00
- KROS $232,844,000.00
- Revenue This Year
- IMXI N/A
- KROS $5,579.44
- Revenue Next Year
- IMXI $1.87
- KROS N/A
- P/E Ratio
- IMXI $8.81
- KROS $33.52
- Revenue Growth
- IMXI N/A
- KROS 85820.30
- 52 Week Low
- IMXI $8.58
- KROS $9.12
- 52 Week High
- IMXI $22.37
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- IMXI 70.52
- KROS 57.26
- Support Level
- IMXI $14.45
- KROS $15.23
- Resistance Level
- IMXI $14.57
- KROS $15.85
- Average True Range (ATR)
- IMXI 0.13
- KROS 0.48
- MACD
- IMXI -0.17
- KROS -0.01
- Stochastic Oscillator
- IMXI 43.24
- KROS 65.55
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.